−3.5SEK
−45.95 MSEK
126.61 MSEK
8.93 M
About DEVYSER DIAGNOSTICS AB
Sector
Industry
CEO
Fredrik Alpsten
Website
Headquarters
Hägersten
Employees (FY)
92
Founded
2004
ISIN
SE0016588867
FIGI
BBG013X97TG8
Devyser Diagnostics AB engages in the development, manufacture and sale of kits for genetic testing in routine diagnostics. Its products are used for complex DNA testing in the areas of hereditary diseases, oncology and post-transplantation monitoring. The firm's products are also used in treating cancer patients and in follow-up transplant patients. The company was founded by Anders Hedrum, Ulf Axel Klangby and Dan Hauzenberger in 2004 and is headquartered in Hägersten, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of DVYSR is 105.50 SEK — it has increased by 1.93% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange DEVYSER DIAGNOSTICS AB stocks are traded under the ticker DVYSR.
DEVYSER DIAGNOSTICS AB is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for DEVYSER DIAGNOSTICS AB has a max estimate of 128.00 SEK and a min estimate of 120.00 SEK.
DVYSR earnings for the last quarter are −0.40 SEK whereas the estimation was −0.48 SEK which accounts for 15.79% surprise. Estimated earnings for the next quarter are −0.50 SEK. See more details about DEVYSER DIAGNOSTICS AB earnings.
DEVYSER DIAGNOSTICS AB revenue for the last quarter amounts to 46.70 M SEK despite the estimated figure of 43.07 M SEK. In the next quarter revenue is expected to reach 45.60 M SEK.
Yes, you can track DEVYSER DIAGNOSTICS AB financials in yearly and quarterly reports right on TradingView.
Like other stocks, DVYSR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DEVYSER DIAGNOSTICS AB stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 92.00 employees. See our rating of the largest employees — is DEVYSER DIAGNOSTICS AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DEVYSER DIAGNOSTICS AB EBITDA is −57.79 M SEK, and current EBITDA margin is −38.53%. See more stats in DEVYSER DIAGNOSTICS AB financial statements.